Lung Cancer Clinical Trial

PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors

Summary

The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Participants must be able to understand, and sign informed consent form.
Age ≥ 18 years.
Participants must self-identify as Hispanic/LatinX.
Individuals must be head and neck cancer survivors (treated locally with surgery, radiation alone, or definitive chemoradiation ≥ 5 years earlier and have no signs/symptoms to suggest recurrence of disease).
Subjects that meet lung cancer (LC) screening eligibility according to United States Preventive Services Task Force (USPSTF21) and/or National Comprehensive Cancer Network (NCCN). For patients with a history of head and neck cancers, the NCCN recommends annual screening with low dose computerized tomography (LDCT) in those who have had a history of 20 pack years of smoking or more. USPSTF21 LC screening eligibility includes adults ages 50-80 that are current smoker or former smokers that quit within 15 years and have a 20 pack-year history or more of smoking.

Exclusion Criteria:

Individuals with pre-established diagnosis of lung cancer.
Participants with current diagnosis of any active malignancy.
Subjects that had undergone lung imaging within previous 3 years.
Pregnant or nursing mothers.
Individuals that received head and neck related treatment less than 5 years before screening.
Individuals with < 20 pack year history of smoking.
Subjects with previous history of distant metastatic head and neck cancer.

Study is for people with:

Lung Cancer

Estimated Enrollment:

44

Study ID:

NCT06124508

Recruitment Status:

Not yet recruiting

Sponsor:

University of Miami

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Miami
Miami Florida, 33136, United States More Info
Coral Olazagasti, MD
Contact
305-243-4334
[email protected]
Coral Olazagasti, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

44

Study ID:

NCT06124508

Recruitment Status:

Not yet recruiting

Sponsor:


University of Miami

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.